Related Subjects:
|Respiratory Failure
|Non invasive ventilation (NIV)
|Intubation and Mechanical Ventilation
|Critical illness neuromuscular weakness
|Multiple Organ Dysfunction Syndrome
|Haemodialysis
|Dobutamine
π‘ Key Point: Patients must be conscious and have sufficient respiratory drive to benefit from NIV.
π΄ Those who are drowsy or unable to protect their airway may need intubation and invasive ventilation.
π Introduction
- π« Normal breathing uses diaphragm + intercostals β negative intrathoracic pressure β air flows into alveoli.
- π¨ NIV: Tight mask/hood with ventilator provides positive pressure to push air in.
- βοΈ Modes: CPAP (continuous) or BiPAP (two pressure levels).
- β
Benefits: avoids intubation, β mortality, β stay length, β costs. Especially used in Type II RF.
π Types of NIV
- π¬οΈ CPAP: Constant pressure through cycle β used in Type I RF (e.g. pulmonary oedema, OSA).
- βοΈ BiPAP: Higher pressure in inspiration (IPAP) + lower in expiration (EPAP). Best for Type II RF with acidosis (e.g. COPD exacerbations).
β Advantages over Invasive Ventilation
- π‘οΈ β Ventilator-associated pneumonia.
- π Shorter admission + lower costs.
- π Less sedation required.
- π¨ Particularly effective in COPD & hypercapnic RF.
π©Ί Applications
- π©ββοΈ Used in both Type I & II RF: COPD exacerbations, pulmonary oedema, post-op support.
- π Requires tight-fitting mask + patient cooperation.
- β‘ Reduces work of breathing, improves gas exchange, recruits alveoli.
- π Can be given at home or in hospital settings.
β
Indications
- pH < 7.35 with hypercarbia (Type II RF).
- Cardiogenic pulmonary oedema without shock.
- Immunosuppressed patients with acute RF.
- Weaning support (esp. COPD).
- Post-op RF (e.g. after lung surgery).
- Palliative symptom relief (breathlessness).
β Contraindications
- π¨ Severe hypoxaemia (< 60 mmHg PaOβ on 100% FiOβ).
- π΄ GCS < 9 / impaired consciousness.
- β Inability to protect airway / excess secretions.
- π€ Facial trauma/burns preventing mask seal.
- π«§ Untreated pneumothorax.
βοΈ NIV Settings
- BiPAP: Start IPAP 10 cmHβO, EPAP 4β5 cmHβO β adjust per ABG/response.
- CPAP: Start 5 cmHβO β β to 10 if needed.
- π― Aim SaOβ > 90% or PaOβ > 60 mmHg with clinical stability.
- β³ If no improvement in 4h β consider intubation.
β οΈ Side Effects
- β¬οΈ Venous return & CO β hypotension risk.
- π€’ Gastric distension β discomfort + aspiration risk.
- π£ Skin breakdown from mask pressure.
π Home NIV
- Consider in chronic RF due to:
- Severe spinal deformity
- Neuromuscular disorders (e.g. DMD, MND)
- Cystic fibrosis
- Central hypoventilation syndrome
- π Often used overnight β improves sleep quality + daytime function.
π¨ Indications for Intubation
- Respiratory arrest or severe distress unresponsive to NIV.
- Severe hypoxaemia (PaOβ < 8 kPa despite FiOβ/NIV).
- Persistent hypercapnia/acidosis despite NIV.
- GCS < 9 or unsafe airway.
- Failure to stabilise after 4h NIV trial.
π References
3 Clinical Cases β Non-Invasive Ventilation (NIV) π·π¨
- Case 1 β Acute exacerbation of COPD π«: A 68-year-old man with known COPD presents with worsening breathlessness, purulent sputum, and confusion. ABG: pH 7.25, PaCOβ 9.2 kPa, PaOβ 7.8 kPa on air. He is tachypnoeic and using accessory muscles. Teaching: This is type 2 respiratory failure with acidosis β clear indication for NIV (usually BiPAP). NIV improves alveolar ventilation, lowers COβ, and reduces need for intubation. Also give controlled Oβ (target sats 88β92%), bronchodilators, steroids, and antibiotics if infective trigger.
- Case 2 β Acute cardiogenic pulmonary oedema β€οΈ: A 72-year-old woman with hypertension and ischaemic heart disease presents with severe breathlessness, orthopnoea, and pink frothy sputum. Oβ sats 82% on 15 L NRB. CXR: bilateral alveolar shadowing. Teaching: CPAP (continuous positive airway pressure) recruits alveoli, reduces preload/afterload, and improves oxygenation. NIV is often life-saving in acute pulmonary oedema alongside diuretics, nitrates, and treatment of the underlying cause (e.g. ACS, arrhythmia).
- Case 3 β Obesity hypoventilation syndrome (chronic use) βοΈ: A 55-year-old woman with BMI 48 presents with morning headaches, somnolence, and dyspnoea. ABG: pH 7.37, PaCOβ 8.5 kPa, PaOβ 7.9 kPa. Overnight oximetry shows desaturation. Teaching: Chronic type 2 respiratory failure due to obesity hypoventilation benefits from long-term nocturnal NIV (BiPAP). This offloads the work of breathing, improves sleep quality, and reduces admissions. Always rule out and treat co-existing OSA.